The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid OfferingBenzinga via Yahoo FinanceOct 04 11:32 AM
NASDAQ: BLUE) Corvus Pharmaceuticals Inc (NASDAQ: CRVS) DelMar Pharmaceuticals Inc (NASDAQ: DMP) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) Erytech Pharma ...
Nasal Sprays Market Size, Top 3 Players Operating Players | ADAPT Pharma, Inc., Egalet Corporation, GlaxoSmithKline plc. and moreMarket Watch1 day ago
Innovation Pharmaceuticals Partnering Provides Momentum For Inflammatory Bowel Disease Programs, Targeting a Substantial and ...Market Watch22 hours ago
- Benzinga2 days ago
The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To LeaveBenzinga via Yahoo FinanceSep 27 11:56 AM
The following is a roundup of top developments in the biotech space over the last 24 hours. Biotech stocks that hit 52-week highs Sept. AstraZeneca plc (NYSE: AZN) GlaxoSmithKline plc (NYSE: ...
- Benzinga via Yahoo FinanceSep 30 20:32 PM
NASDAQ: GILD) Type of Application: sNDA Candidate: Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) Indication: Pre-exposure prophylaxis, or PrEP, for HIV-1 infection Date ...
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision...Benzinga via Yahoo FinanceSep 26 11:54 AM
Coherus Biosciences Inc (NASDAQ: CHRS) The Medicines Company (NASDAQ: MDCO) (Biotech stocks that hit 52-week lows Sept.
- Zacks via Yahoo FinanceOct 07 14:25 PM
Theravance's (TBPH) newly-launched COPD drug Yupelri is witnessing a solid adoption while its pipeline programs are also progressing well. However, excessive reliance on Yupelri for revenues is a woe.
The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug ReadoutBenzinga via Yahoo FinanceOct 11 12:14 PM
The Medicines Company (NASDAQ: MDCO) Ra Pharmaceuticals Inc (NASDAQ: RARX) (announced a deal to be bought by Belgium's UCB) (Biotech stocks that hit 52-week lows Oct. 10.
- Benzinga via Yahoo FinanceOct 13 20:33 PM
NASDAQ: AMGN)'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: CLVLY)'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory ...
- Bloomberg via Yahoo FinanceOct 09 11:27 AM
A state court jury in Philadelphia Tuesday concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the punishment award in the first Pennsylvania case in which ...
- related to Janssen Pharmaceuticals Inc